Hrt Financial LP Cybin Inc. Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$0.3 - $0.46 $1,691 - $2,593
5,637 Added 23.44%
29,684 $12,000
Q4 2023

Feb 09, 2024
BUY
$0.38 - $0.65 $9,137 - $15,630
24,047 New
24,047 $9,000
Q2 2023

Aug 11, 2023
BUY
$0.23 - $0.39 $3,374 - $5,722
14,672 New
14,672 $5,000
Q4 2022

Feb 10, 2023
BUY
$0.26 - $0.64 $6,445 - $15,865
24,790 New
24,790 $7,000

Others Institutions Holding CYBN

# of Institutions
8
Shares Held
66.1K
Call Options Held
0
Put Options Held
0
View Full List

About CYBIN INC.

CYBN Quotes by TradingView
  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $1.65B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email